XML 25 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
 12 Months Ended 123 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2011
Cash flows from operating activities:        
Loss for the period $ (2,364,339) $ (2,788,446) $ (1,202,296) $ (12,517,519)
Adjustments to reconcile loss for the period to net cash used in operating activities:        
Depreciation 23,045 19,153 20,837 132,486
Increase in liability for employee rights upon retirement 1,127 16,284 34,485 223,702
Stock-based compensation 378,072 14,575 12,171 1,230,903
Stock-based interest compensation to convertible notes holders    1,214,943    1,214,943
Linkage difference on principal of loans from stockholders 24,934 15,909 10,617 177,049
Interest on convertible notes    78,192    78,192
Gain on sale of property and equipment    (912)    (912)
Gain from trading marketable securities       (756) (12,920)
Changes in assets and liabilities:        
Decrease (increase) in other current assets (23,968) (46,562) 577 (83,287)
Increase (decrease) in accounts payable 64,697 (14,120) (8,530) 73,142
Increase (decrease) in other current liabilities (19,681) 123,147 (29,835) 207,386
Net cash used in operating activities (1,916,113) (1,367,837) (1,162,730) (9,276,835)
Cash flows from investment activities:        
Decrease (increase) in funds in respect of employee rights upon retirement (14,436) (25,387) (28,819) (102,804)
Purchase of property and equipment (54,619) (8,725) (5,007) (208,773)
Proceeds from sale of property and equipment    4,791    4,791
Investment in marketable securities          (388,732)
Proceeds from sale of marketable securities       135,195 406,995
Short-term loan granted to related party, net of repayments       127,551 (14,252)
Net cash provided by (used in) investment activities (40,183) (29,321) 228,920 (302,775)
Cash flows from financing activities        
Credit from banking institutions (repayment) (18,669) (75,845) 88,265 (6,218)
Proceeds from issuance of convertible notes    1,144,000    1,144,000
Repayment of convertible notes    (527,396)    (527,396)
Proceeds from issuance of Common Stock, net of issuance expenses 2,401,214 2,357,032 378,000 10,406,380
Proceeds from stockholders loans          347,742
Net cash provided by financing activities 2,382,545 2,897,791 466,265 11,364,508
Effect of exchange rate changes on cash and cash equivalents (23,993) (68,417) 3,275 111,606
Increase (decrease) in cash and cash equivalents 402,256 1,432,216 (464,270) 1,896,504
Cash and cash equivalents at beginning of the period 1,494,248 62,032 526,302   
Cash and cash equivalents at end of the period 1,896,504 1,494,248 62,032 1,896,504
Supplementary information on financing activities not involving cash flows:        
Conversion to convertible notes to Common Stock (see Notes 10C)    694,796      
Fair value of warrants with down-round protection issued in connection with Common Stock issuances (See Note 9C) $ 83,899